A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cells

被引:24
|
作者
Fahmy, Tarek M. [1 ]
Schneck, Jonathan P.
Saltzman, W. Mark
机构
[1] Yale Univ, Malone Engn Ctr, New Haven, CT 06511 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD USA
关键词
peptide-loaded major histocompatibility complex; T-cell receptor; polyethylene glycol; polyamidoamine dendrimer; streptavidin;
D O I
10.1016/j.nano.2006.11.010
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Both monoclonal T cell-specific antibodies and multivalent major histocompatibility complex proteins are used as diagnostic reagents for T cell-mediated diseases. However, their widespread use as vehicles for drug delivery has been hindered by the lack of versatile methods that couple the targeting potential of these reagents with drugs of clinical relevance. To address this problem, we engineered a multivalent nanoscopic drug carrier that flexibly tethers to a variety of T-cell antigens. Our carriers bound their target T cells specifically and with enhanced sensitivities as compared with free antigen. Additionally, they consistently inhibited the proliferation of the target T cells in vitro and in vivo, whereas drug-free constructs elicited strong stimulation of the target populations. As a result of the flexibility of incorporating multivalent antigen and drug, these carriers have wide potential use as sensitive T-cell detection reagents as well as promising immunostimulatory or immunosuppressive tools. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:75 / 85
页数:11
相关论文
共 50 条
  • [31] The emerging family of RORγt+ antigen-presenting cells
    Jakub Abramson
    Jan Dobeš
    Mengze Lyu
    Gregory F. Sonnenberg
    Nature Reviews Immunology, 2024, 24 : 64 - 77
  • [32] Synthetic Antigen-Presenting Cells for Adoptive T Cell Therapy
    Dahotre, Shreyas N.
    Romanov, Anna M.
    Su, Fang-Yi
    Kwong, Gabriel A.
    ADVANCED THERAPEUTICS, 2021, 4 (08)
  • [33] Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells
    Rao, M
    Alving, CR
    ADVANCED DRUG DELIVERY REVIEWS, 2000, 41 (02) : 171 - 188
  • [34] Methods of delivery to antigen-presenting cells: Development of new and improved vaccines
    Apostolopoulos, Vasso
    MOLECULAR PHARMACEUTICS, 2007, 4 (01) : 1 - 3
  • [35] Enhanced T cell proliferation and increased responder frequency following delivery of antigen to the antigen-presenting cell; B cell dependency and use in detection of autoreactive T cells
    Stevens, EJ
    Peakman, M
    JOURNAL OF IMMUNOLOGICAL METHODS, 1998, 215 (1-2) : 59 - 70
  • [36] ANTIGEN-PRESENTING HUMAN T-CELLS AND ANTIGEN-PRESENTING B-CELLS INDUCE A SIMILAR CYTOKINE PROFILE IN SPECIFIC T-CELL CLONES
    WYSSCORAY, T
    GALLATI, H
    PRACHT, I
    LIMAT, A
    MAURI, D
    FRUTIG, K
    PICHLER, WJ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (12) : 3350 - 3357
  • [38] Tolerogenic antigen-presenting cells -: Regulation of the immune response by TGF-β-treated antigen-presenting cells
    Kosiewicz, MM
    Alard, P
    IMMUNOLOGIC RESEARCH, 2004, 30 (02) : 155 - 170
  • [39] Phenotype, antigen-presenting capacity, and migration of antigen-presenting cells in young and old age
    Donnini, A
    Argentati, K
    Mancini, R
    Smorlesi, A
    Bartozzi, B
    Bernardini, G
    Provinciali, M
    EXPERIMENTAL GERONTOLOGY, 2002, 37 (8-9) : 1097 - 1112
  • [40] FUNCTIONAL ACTIVATION OF ENCEPHALITOGENIC T-CELLS IN THE ABSENCE OF ANTIGEN-PRESENTING CELLS
    REIZIS, B
    MOR, F
    COHEN, IR
    INTERNATIONAL IMMUNOLOGY, 1995, 7 (08) : 1375 - 1379